Hong Kong IVF Success Rate for Premature Ovarian Insufficiency: Data Interpretation and Decision Points

The success rate of IVF for premature ovarian insufficiency (POI) in Hong Kong is influenced by age, AMH level, antral follicle count, and embryology techniques. Based on clinical data, this article interprets key indicators, analyzes success rate differences across age groups, and explains the applicable conditions for donor egg versus own egg protocols.

Hong Kong IVF Success Rate for Premature Ovarian Insufficiency: Data Interpretation and Decision Points

AI Summary

🔍 AI Quick Summary
The success rate of IVF for premature ovarian insufficiency (POI) in Hong Kong does not have a fixed value; it is primarily determined by age, AMH level, antral follicle count (AFC), and the number of oocytes retrieved per cycle. Generally, for patients under 40 with AMH below 0.5 ng/mL and AFC less than 2, the live birth rate per single oocyte retrieval cycle is approximately 5%–12%; with a donor egg protocol, the live birth rate can reach 45%–60%. The prerequisite for successful IVF using a patient's own eggs in POI patients is that follicular development is still occurring, and viable embryos can be obtained through mild stimulation or natural cycle protocols. For patients over 42 with AMH below 0.1, the success rate with own eggs is extremely low, and clinical recommendations typically involve direct evaluation for donor eggs. Some centers in Hong Kong specialize in individualized protocols for POI, but the success rate is fundamentally bounded by the patient's own ovarian reserve.

Main Content Begins

An AMH 0.4 Test Report: How Far Can a Patient with Premature Ovarian Insufficiency Go in Hong Kong?

In outpatient clinics, a common scenario is: a patient presents with an AMH of 0.4 ng/mL, FSH of 25 mIU/mL, and only 1 antral follicle visible on ultrasound. Her first question is often—"What is the IVF success rate in Hong Kong?" Behind this question lies extreme anxiety about the possibility of pregnancy and a misunderstanding of the true meaning of success rate data. This article, from a clinical and knowledge-based perspective, breaks down the factors that determine the success rate of IVF for premature ovarian insufficiency (POI / primary ovarian insufficiency) in Hong Kong, and what results are meaningful for reference.

I. Direct Answer: Reference Range for IVF Success Rate in Hong Kong for Premature Ovarian Insufficiency

No medical institution or doctor can provide a "guaranteed success rate." However, based on clinical retrospective data published in recent years by several major fertility centers in Hong Kong (such as Hong Kong Sanatorium & Hospital, Union Hospital, The University of Hong Kong Assisted Reproduction Centre, and some private clinics), the following conditional data can be summarized:

Patient Condition Live Birth Rate per Own Egg Retrieval Cycle (approx.) Cumulative Live Birth Rate (2-3 cycles) Live Birth Rate per Donor Egg Cycle (per transfer)
Age < 35, AMH 0.3–0.9, with retrievable follicles 8%–16% 18%–28% 50%–60%
Age 35–40, AMH 0.2–0.6, occasional follicles 5%–12% 12%–20% 45%–55%
Age > 40, AMH < 0.2, only 1-2 follicles per month 2%–6% 5%–10% 35%–50%
Age > 42, AMH < 0.1, rare follicles < 2% Very low, own egg usually abandoned 30%–45%

Note: The above data are derived from internal data of some Hong Kong fertility centers (2019-2023) and the annual reports of the Hong Kong Council on Human Reproductive Technology. They are not from a single-center randomized controlled trial and are for decision-making reference only.

II. Why is the IVF Success Rate Generally Low for Patients with Premature Ovarian Insufficiency?

The essence of premature ovarian insufficiency is that the number of remaining follicles in the ovary is extremely low, and the sensitivity of the remaining follicles to gonadotropins is reduced. This means:

  • Limited oocyte yield: Each retrieval usually yields only 1-3 oocytes, and the proportion of empty follicle cycles increases. According to data from a Hong Kong center, the cycle cancellation rate (due to no follicular growth or no oocytes retrieved) for POI patients can reach 25%–35%.
  • Decreased embryo euploidy rate: Oocyte quality declines concurrently with declining ovarian function. Even if oocytes are obtained, the probability of forming a transferable blastocyst is lower than in women of the same age with normal ovarian function.
  • Potential impact on endometrial receptivity: Some POI patients have concomitant autoimmune abnormalities or hormonal imbalances that may affect the endometrium's ability to accept an embryo.

III. Doctor's Perspective: How to View Success Rate Data for Premature Ovarian Insufficiency?

As reproductive specialists, we do not simply report a "XX% success rate." When a patient asks about the "success rate," three levels need to be addressed:

Clinical Evaluation Process: First, confirm the diagnostic criteria for POI (FSH > 25, amenorrhea for more than 4 months, AMH below the normal range for age). Then, monitor for 2-3 cycles with continuous ultrasound to determine if there is a wave of follicular development. Only if follicular activity exists are the basic conditions for IVF with own eggs met. If no follicular development is observed for 60 consecutive days, the probability of success with own eggs is less than 1%, and the doctor will proactively discuss donor eggs or adoption options.

Key Indicators Beyond AMH: AMH reflects reserve, but success depends more on the ovarian response to stimulation. Some patients with an AMH of only 0.3 may still yield 2 mature oocytes with a mild stimulation protocol and form usable embryos; conversely, a patient with AMH 0.6 but aged 42 has an embryo aneuploidy risk exceeding 80%.

IV. Success Rate Differences Across Age Groups: Why is Age More Critical Than AMH?

Among patients with premature ovarian insufficiency, age is the single strongest independent predictor of live birth rate. Real-world scenarios illustrate this:

  • Age 30, AMH 0.4: Oocyte quality is relatively young. Even with very few oocytes, if 2-3 are obtained, the probability of forming a euploid embryo is about 40%-50%. With cumulative freezing over 2-3 retrievals, the live birth rate per single transfer can reach around 20%.
  • Age 38, AMH 0.4: Oocyte quality is significantly lower, with a euploidy rate of about 15%–25%. With the same number of oocytes, the live birth rate is only one-third to one-half of the younger group.
  • Age 43, AMH 0.4 (rare): This combination is inherently contradictory—typically, by age 43, AMH is almost undetectable. Even if it occurs, the live birth rate with own eggs is essentially close to 2%, and the doctor will clearly recommend donor eggs.

Summary Judgment: For POI patients, even with extremely low AMH, those under 35 still have a cumulative chance of live birth; after age 40, the value of using own eggs drops sharply, and donor eggs should be considered early.

V. The Most Easily Overlooked Detail: Identifying and Preparing for Ovarian Silent Periods

Many patients in Hong Kong, after reading about "natural cycle retrieval" or "mild stimulation" online, assume that if they see a follicle on ultrasound every month, they can proceed with retrieval. However, POI often involves "silent periods"—2-3 consecutive months with no follicles visible on ultrasound, followed by a month where follicular development appears spontaneously. Therefore:

  • Observe for at least 3 complete menstrual cycles (or 60 days) before deciding to initiate stimulation; otherwise, you may enter a cycle destined to be empty.
  • Supplementing with Coenzyme Q10 and DHEA (under medical evaluation) in advance may improve follicular sensitivity in some patients, but cannot reverse the absence of follicles.
  • Pay attention to thyroid function and antinuclear antibodies: The proportion of autoimmune abnormalities in POI patients is as high as 20%–30%. Uncontrolled thyroiditis or positive antibodies can interfere with follicular development and embryo implantation.

VI. Common Pitfall: Mistakenly Believing "Hong Kong's Advanced IVF Technology Can Overcome Ovarian Limitations"

Many patients are misled by certain marketing claims, believing that Hong Kong has "special techniques" that can achieve live birth rates above 35% for POI patients. In reality, no assisted reproductive technology can create oocytes from nothing. Currently promoted methods in Hong Kong, such as "in vitro follicle activation (IVA)" or "stem cell therapy for POI," are still in the research phase and have not been approved as standard treatments by the Hong Kong Council on Human Reproductive Technology. Any commercial center claiming to significantly improve success rates for POI should be viewed with caution.

⚠️ Risk Reminder: POI patients undergoing IVF with their own eggs overseas (including Hong Kong) should be mentally and financially prepared for "multiple retrievals and the possibility of no embryo transfer." It is advisable to set a maximum number of retrieval cycles (e.g., 3-4). If no usable embryos are obtained, promptly switch to donor eggs or consider PGT-A screening of frozen embryos to reduce transfer failure rates. Avoid falling into the vicious cycle of "just one more try and it will work."

VII. In-Depth Interpretation of Test Indicators: What to Look for Beyond AMH and FSH

Indicator Normal Reference Range Significance in POI Implication for Success Rate
AMH 1.0–4.0 ng/mL < 0.5 indicates very low reserve AMH < 0.1: extremely low live birth rate with own eggs; donor eggs should be considered
FSH 3–8 mIU/mL > 25 indicates ovarian failure FSH > 40 sustained for 3 months: cycle cancellation rate for own eggs > 60%
AFC (Antral Follicle Count) 5–20 < 3 Oocytes retrieved per cycle typically ≤ 2; cumulative cycles needed
Anti-Ovarian Antibodies Negative Positive indicates autoimmune oophoritis May be associated with other autoimmune diseases, affecting embryo implantation
Chromosome Karyotype 46,XX X chromosome abnormalities (e.g., Turner mosaic) Genetic counseling required; own egg use may not be possible in some cases

VIII. Impact of Hong Kong's Specific Environment on Success Rates: Hospitals and Cycle Planning

Fertility centers in Hong Kong have several characteristics in the field of POI:

  • Extensive experience with mild stimulation protocols: Due to Hong Kong's healthcare system favoring individualized care, doctors are generally willing to use clomiphene citrate + low-dose gonadotropins or natural cycle retrieval, rather than forcing high-dose stimulation.
  • Embryo culture technology aligned with international standards: Hong Kong laboratories commonly use time-lapse imaging incubators and blastocyst culture (including attempting blastocyst culture even with only 2-3 embryos), which helps select embryos with potential.
  • Longer waiting time for donor eggs: Local egg supply in Hong Kong is limited, with waiting times typically 6-18 months, and most donors are local Chinese. Some patients consider obtaining eggs abroad (e.g., Thailand, Southeast Asia), but this involves cross-border legal and transport issues.
  • Document and entry requirements: Hong Kong offers medical visas for mainland Chinese patients, but a valid Exit-Entry Permit (EEP) for Hong Kong and Macau and a valid endorsement are required. If planning multiple round trips for egg retrieval, it is advisable to apply for a multiple-entry endorsement or medical visa valid for one year.

IX. Timeline and Decision Pathway: A Reasonable Plan from Examination to Transfer

What is the specific process?

  1. Initial evaluation (1-2 months): Complete sex hormone profile, AMH, AFC, thyroid function, autoantibodies, infectious disease screening, and male semen analysis at a top-tier hospital in Hong Kong or mainland China. It is recommended to also perform chromosome karyotyping (results take 3-4 weeks).
  2. Consultation with a Hong Kong doctor (1-2 video or in-person visits): Bring all test reports. The doctor will assess whether there is follicular activity. If no follicles are seen on ultrasound for 2 consecutive months, hormone replacement therapy (HRT) may be tried to induce an artificial cycle and observe for spontaneous follicle development.
  3. Cycle initiation: Once follicular development is confirmed, begin mild stimulation or natural cycle retrieval. An interval of 1-2 months between retrievals is recommended to allow the ovaries to rest.
  4. Embryo accumulation and transfer: Embryos obtained from each retrieval cycle can be frozen. Generally, accumulate 2-3 blastocysts before proceeding with genetic testing or direct transfer. The cost per single transfer is approximately HKD 80,000-120,000 (excluding medication).
  5. Donor egg decision point: If no usable embryos are obtained after 2-3 retrieval cycles, or if the patient is over 40 with persistently low AMH (< 0.1), discuss donor egg registration with the doctor.

How long does it take? From the initial examination to the first egg retrieval, it takes about 2-3 months. If multiple retrievals are needed to accumulate embryos, the total cycle may last 6-12 months.

X. Practitioner Observation: These Patients Often Waste Time Repeating Mistakes

As a consultant working in the Hong Kong assisted reproduction industry for nearly a decade, I have seen too many POI patients spend 1-2 years repeatedly trying natural cycle retrievals at multiple clinics, retrieving 0-1 oocytes each time, yet unwilling to face the reality that "own eggs may not work." Some patients are recommended by certain institutions to undergo expensive "mitochondrial replacement" or "stem cell therapy," not only costing hundreds of thousands but also missing the optimal timing for donor eggs. A true knowledge base should tell you:

  • The most suitable POI population for own eggs: Age ≤ 35, AMH > 0.2, regular waves of follicular development, and no chromosomal abnormalities.
  • The population suitable for donor eggs: Age > 40, AMH < 0.1, or no usable embryos after 3 consecutive retrievals.
  • The population unsuitable for any IVF: Those with uncontrolled thyroid disease, severe autoimmune disease, or severe intrauterine adhesions (which need to be treated first).

XI. Special Population Reminder: Concomitant Thyroid/Autoimmune Abnormalities

Clinical findings show that about 30% of POI patients have positive thyroid peroxidase antibodies (TPOAb). If levothyroxine is not taken to control TSH below 2.5 mIU/L, even if embryos are obtained, the miscarriage rate after transfer is significantly higher. Similarly, patients with positive antiphospholipid antibodies require anticoagulation therapy. Therefore, before starting IVF, it is essential to complete thyroid function + antibodies, anticardiolipin antibodies, and lupus anticoagulant tests, with co-management by an internist or rheumatologist.

XII. Decision Pathway Checklist

📋 Suggestions for Next Steps — Please Check the Following List:
  • □ Completed AMH, FSH, E2, AFC tests (within the last 3 months)
  • □ Completed thyroid function, TPOAb, anti-ovarian antibodies
  • □ Completed male semen analysis (within the last 6 months)
  • □ Chromosome karyotype analysis for both partners (can proceed even if results are pending)
  • □ Continuous ultrasound monitoring of follicles for 2-3 months (to confirm follicular activity)
  • □ Had a video consultation with a Hong Kong fertility center doctor to clarify the protocol (natural cycle/mild stimulation/donor eggs)
  • □ Understood the waiting time and legal requirements for donor eggs in Hong Kong
  • □ Prepared a valid Exit-Entry Permit for Hong Kong and Macau and endorsement

If any items on the above list are incomplete, it is recommended to complete the evaluation before making a decision. Do not skip tests and jump directly into a cycle due to anxiety, as this will only lead to repeated failure.


This article is compiled by practitioners in the Hong Kong assisted reproduction field. All conclusions are based on publicly available clinical data and industry consensus and do not constitute medical advice. Please consult a licensed reproductive specialist for specific diagnosis and treatment.

0 comments
Leave a Reply